These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38090119)

  • 21. Time to positivity of blood cultures in bloodstream infections with
    Bläckberg A; Lundberg K; Svedevall S; Nilson B; Rasmussen M
    Infect Dis (Lond); 2023 May; 55(5):333-339. PubMed ID: 36847483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymicrobial Bacteremia Involving
    Liu Q; Wu J; Wang Z; Wu X; Wang G; Ren J
    Surg Infect (Larchmt); 2019; 20(4):317-325. PubMed ID: 30735082
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk factors for in-hospital mortality in patients with type 2 diabetes complicated by community-acquired Klebsiella pneumoniae bacteremia.
    Huang CH; Tsai JS; Chen IW; Hsu BR; Huang MJ; Huang YY
    J Formos Med Assoc; 2015 Oct; 114(10):916-22. PubMed ID: 26315482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to positivity of blood culture is a risk factor for clinical outcomes in Staphylococcus aureus bacteremia children: a retrospective study.
    Li Y; Li Q; Zhang G; Ma H; Wu Y; Yi Q; Jiang L; Wan J; Suo F; Luo Z
    BMC Infect Dis; 2019 May; 19(1):437. PubMed ID: 31101087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case-control study.
    Namikawa H; Niki M; Niki M; Yamada K; Nakaie K; Sakiyama A; Oinuma KI; Tsubouchi T; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2291-2297. PubMed ID: 31605255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult Klebsiella pneumoniae bacteremia at emergency department: A single center experience.
    Chang EK; Kao KL; Tsai MS; Yang CJ; Huang YT; Liu CY; Liao CH
    J Microbiol Immunol Infect; 2015 Dec; 48(6):684-91. PubMed ID: 26510516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time to Positivity as a Prognostic Tool in the Performance of Short-Term Subculture for MALDI-TOF MS-Based Identification of Microorganisms from Positive Blood Cultures in Pediatric Patients.
    Fang C; Zhou Z; Li J; Zhou M; Chen X
    Curr Microbiol; 2020 Jun; 77(6):953-958. PubMed ID: 31989212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong.
    Pau CK; Ma FF; Ip M; You JH
    Infect Dis (Lond); 2015 May; 47(5):283-8. PubMed ID: 25697339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection.
    Willmann M; Kuebart I; Vogel W; Flesch I; Markert U; Marschal M; Schröppel K; Autenrieth IB; Hölzl F; Peter S
    J Infect; 2013 Nov; 67(5):416-23. PubMed ID: 23817209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia.
    Rodríguez OL; Sousa A; Pérez-Rodríguez MT; Martínez-Lamas L; Suárez RL; Martínez CT; Pino CP; Vidal FV; Pérez-Landeiro A; Casal MC
    Medicine (Baltimore); 2021 Apr; 100(14):e24880. PubMed ID: 33832068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia.
    Álvarez R; Viñas-Castillo L; Lepe-Jiménez JA; García-Cabrera E; Cisneros-Herreros JM
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2191-5. PubMed ID: 22298241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing trends in clinical characteristics and antibiotic susceptibility of
    Hyun M; Noh CI; Ryu SY; Kim HA
    Korean J Intern Med; 2018 May; 33(3):595-603. PubMed ID: 29117671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection.
    Cheng J; Li Q; Zhang G; Xu H; Li Y; Tian X; Chen D; Luo Z
    BMC Pediatr; 2022 Oct; 22(1):568. PubMed ID: 36192715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes After Bacteremia Caused by Carbapenem-Resistant Enterobacterales.
    Satlin MJ; Chen L; Gomez-Simmonds A; Marino J; Weston G; Bhowmick T; Seo SK; Sperber SJ; Kim AC; Eilertson B; Derti S; Jenkins SG; Levi MH; Weinstein MP; Tang YW; Hong T; Juretschko S; Hoffman KL; Walsh TJ; Westblade LF; Uhlemann AC; Kreiswirth BN
    Clin Infect Dis; 2022 Dec; 75(12):2066-2075. PubMed ID: 35522019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to positivity in bloodstream infection is not a prognostic marker for mortality: analysis of a prospective multicentre randomized control trial.
    Hamilton F; Evans R; Ghazal P; MacGowan A
    Clin Microbiol Infect; 2022 Jan; 28(1):136.e7-136.e13. PubMed ID: 34111588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.
    Thom KA; Schweizer ML; Osih RB; McGregor JC; Furuno JP; Perencevich EN; Harris AD
    BMC Infect Dis; 2008 Sep; 8():116. PubMed ID: 18793400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors of Streptococcus pneumoniae infection in adults.
    Hifumi T; Fujishima S; Abe T; Kiriu N; Inoue J; Kato H; Koido Y; Kawakita K; Kuroda Y; Sasaki J; Hori S
    Am J Emerg Med; 2016 Feb; 34(2):202-6. PubMed ID: 26508390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of appropriate empirical antibiotics on clinical outcomes in
    Man MY; Shum HP; Li KC; Yan WW
    Hong Kong Med J; 2021 Aug; 27(4):247-257. PubMed ID: 34393109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care.
    Tseng CP; Wu HS; Wu TH; Lin YT; Fung CP
    J Microbiol Immunol Infect; 2013 Jun; 46(3):217-23. PubMed ID: 22832028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
    Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.